FMP
BMY.RT

Financial Management Professionals’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Financial Management Professionals’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-127
Closed – – 743
2020
Q4 		$0 Hold
127
– – ﹤0.01% 694
2020
Q3 		$0 Hold
127
– – ﹤0.01% 665
2020
Q2 		$0 Hold
127
– – ﹤0.01% 644
2020
Q1 		$0 Hold
127
– – ﹤0.01% 393
2019
Q4 		$0 Buy
+127
New +$330 ﹤0.01% 373

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Financial Management Professionals's BMY.RT Position: Q1 2021 in Review

Financial Management Professionals sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 127 shares.

Financial Management Professionals first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $0 in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Financial Management Professionals reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Financial Management Professionals sold 127 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Financial Management Professionals first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Financial Management Professionals's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $0 in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Financial Management Professionals's 13F filing for Q1 2021, filed 26 Apr 2021.